Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
Clinical trial NCT03790891 · UNKNOWN
Trial details
- NCT number
- NCT03790891
- Sponsor
- Timmune Biotech Inc.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-05
- Primary completion
- 2021-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.